Cite
HARVARD Citation
Verstockt, B. et al. (2019). Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates. Journal of Crohn's and colitis. pp. 864-872. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Verstockt, B. et al. (2019). Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates. Journal of Crohn's and colitis. pp. 864-872. [Online].